Delivery Order SPE2DB20D2104-SPE2DB22FS39P

Award Date 4/12/22
Potential Completion Date 4/13/22
Potential Value $3K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $3,408.24, is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for...
This federal contract award, valued at $1,936.65, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award is for the delivery of 4564413056 - MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical. This IDC serves as the primary...
This federal contract award, valued at $87,389.83, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The award is a delivery order contract with a firm fixed price pricing type and has an ultimate completion date of November 2, 2023. The contract was made through full and open competition, with no set-aside designation. Amerisourcebergen Drug Corp...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $9,053.59 for the supply of MULTAQ 400 MG TABLET 60S. The contract has a firm fixed price and was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Cencora, Inc. holds with the DLA Troop Support Medical. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $25,747.81 firm fixed-price delivery order is for the pharmaceutical product MULTAQ 400 MG TABLET 60S. The award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This single-award IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $7,725.92 firm-fixed-price delivery order is for the supply of MULTAQ 400 MG TABLET 60S, a pharmaceutical product, to support military and veterans' healthcare programs. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,857.00 firm fixed-price delivery order is for the provision of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of April 28, 2023. Amerisourcebergen Drug Corp is the prime contractor for this award and holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $6,204.20 firm fixed-price delivery order for the supply of MULTAQ 400 MG TABLET 60S. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has no set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $13,920.54 firm fixed-price delivery order is for the supply of MULTAQ 400 MG TABLET 60S, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $37,415.59 firm fixed-price delivery order is for the pharmaceutical product MULTAQ 400 MG TABLET 60S. The award has an ultimate completion date of January 16, 2024 and was made without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB22FS39P
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,953.39 firm-fixed-price contract is for the delivery of MULTAQ 400 MG TABLET 60S, a pharmaceutical product.

The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Additionally, Cencora, Inc. holds a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

This contract award does not have a set-aside designation, indicating it was awarded through full and open competition. The DLA, a defense agency, is the funding agency for this contract, which aligns with Amerisourcebergen's focus on supporting military and veterans' healthcare systems through its federal contract awards.

Generated 2/27/25, 9:54 AM